Citation Impact
Citing Papers
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Hallmarks of aging: An expanding universe
2023 Standout
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
2014
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
VHL and Kidney Cancer
2003 StandoutNobel
Hallmarks of Health
2020
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cells
2002 StandoutNobel
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Gene
2020
The Next Decade of Immune Checkpoint Therapy
2021 Nobel
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
2002 StandoutNobel
Works of Vivek Narayan being referenced
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
2020
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma
2012
Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease
2020
Phase II study of the oral HIF-2α inhibitor MK-6482 for Von Hippel-Lindau disease–associated renal cell carcinoma.
2020